Teva: Ramipril
Teva has launched Ramipril Capsules, which are available in 2.5 mg, 5 mg, and 10 mg strengths, in bottle sizes of 100.
Taro: Cetirizine Hydrochloride Syrup
Taro Pharma got final approval from the USFDA for its ANDA for Cetirizine Hydrochloride Syrup, 1 mg / 1 mL
Cipla: Lamivudine/Stavudine
FDA granted tentative approval to Cipla on fixed dose combination Lamivudine/Stavudine tablets, 30mg/6mg & 60mg/12mg for oral suspension for pediatric. The application was reviewed under President's Emergency Plan for AIDS Relief (PEPFAR)
Teva has launched Ramipril Capsules, which are available in 2.5 mg, 5 mg, and 10 mg strengths, in bottle sizes of 100.
Taro: Cetirizine Hydrochloride Syrup
Taro Pharma got final approval from the USFDA for its ANDA for Cetirizine Hydrochloride Syrup, 1 mg / 1 mL
Cipla: Lamivudine/Stavudine
FDA granted tentative approval to Cipla on fixed dose combination Lamivudine/Stavudine tablets, 30mg/6mg & 60mg/12mg for oral suspension for pediatric. The application was reviewed under President's Emergency Plan for AIDS Relief (PEPFAR)
